CONFORTI, FABIO

CONFORTI, FABIO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.011 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center 2024 Valenza, CarmineCastellano, GraziaSantoro, CelesteVivanet, GraziaTrapani, DarioConforti, FabioVeronesi, PaoloCurigliano, Giuseppe + Article (author) -
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study 2023 Conforti, FabioVivanet, GraziaCorti, ChiaraCurigliano, Giuseppe + Article (author) -
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers 2023 P. ZagamiG. AntonarelliG. CuriglianoF. Conforti + Article (author) -
Sex and cancer immunotherapy: Current understanding and challenges 2022 Minucci, SaverioViale, GiuseppeConforti, Fabio + Article (author) -
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 2022 Conforti, FabioAgostoni, PiergiuseppeCarugo, StefanoGuazzi, MarcoPiepoli, MassimoMapelli, MassimoPeveri, GiuliaProvenzale, Giovanni + Article (author) -
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis 2022 Corso, GiovanniConforti, FabioVeronesi, PaoloSajjadi, ElhamVenetis, KonstantinosFusco, Nicola + Article (author) -
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy 2022 Corti, ChiaraConforti, FabioCurigliano, Giuseppe + Article (author) -
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group 2022 Antonarelli, GabrieleCorti, ChiaraPerrino, MatteoManglaviti, SaraCurigliano, GiuseppeConforti, Fabio + Article (author) -
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial 2022 Conforti, FabioDella Vigna, PaoloPerrino, MatteoZagami, PaolaCorti, ChiaraGuerini-Rocco, ElenaDe Vincenzo, Fabio + Article (author) -
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis 2022 Giugliano, FedericaGalli, GiuliaCorti, ChiaraUliano, JacopoVivanet, GraziaCurigliano, GiuseppeConforti, Fabio + Article (author) -
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML 2022 Ceccacci E.Conforti F.Ravasio R.Massignani E.Minucci S.Bonaldi T. + Article (author) -
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 2021 Conforti F.Minucci S.Veronesi P.Viale G. + Article (author) -
Metaplastic breast cancer: Prognostic and therapeutic considerations 2020 Corso G.De Camilli E.Bottiglieri L.Conforti F.Viale G.Veronesi P. + Article (author) -
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 2019 Conforti, FabioViale, GiuseppeRocco, Elena GueriniVingiani, AndreaColleoni, Marco + Article (author) -
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 2019 Conforti F.Viale G. + Article (author) -